Sort
326,823 grants matching “clinical trial”
Center for the Study of Aphasia Recovery (C-STAR)
$2,456,681Julius Fridriksson · University Of South Carolina At Columbia · P50 · FY2023 · DC
Weill Cornell Medical College-New Jersey Medical School Clinical Trials Unit
$2,456,647Roy M Gulick · Weill Medical Coll Of Cornell Univ · UM1 · FY2014 · AI
Development of a recombinant trimeric RSV-F vaccine (DS-Cav1)
$2,456,526Frank Arnold · National Institute Of Allergy And Infectious Diseases · ZIA · FY2017 · AI
Beta1-selective blockade for prevention of postmenopausal bone loss: A randomized controlled trial
$2,456,365Sundeep Khosla · Mayo Clinic Rochester · R01 · FY2023 · AG
Translational Research Program in Colorectal Cancer Disparities
$2,455,587Ulrike Peters · Fred Hutchinson Cancer Center · P50 · FY2025 · CA
NIH StrokeNet National Clinical Coordinating Center (NCC)
$2,455,413Joseph Paul Broderick · University Of Cincinnati · U01 · FY2025 · NS
Targeted Clincial Trials to Reduce the Risk of Antimocribal Resistance
$2,455,261Keith Kaye · Wayne State University · N01 · FY2013 · AI
Clinical Evaluation of PET Radiotracers
$2,455,225Robert Innis · National Institute Of Mental Health · ZIA · FY2022 · MH
University of Pittsburgh Clinical Trials Unit
$2,455,069John W Mellors · University Of Pittsburgh At Pittsburgh · U01 · FY2011 · AI
B Lymphocyte-Mediated Autoimmunity in Pain After Trauma
$2,454,998David J Clark · Palo Alto Veterans Instit For Research · R01 · FY2020 · NS
Development of a Next Generation Anthrax Vaccine, dmPA7909
$2,454,564Sukjoon Park · Emergent Product Development Gaithersbur · U01 · FY2009 · AI
Manufacturing of ABCA1 agonist small molecule peptide CS6253 to support chronic toxicology studies in Wistar rats and Cynomolgus monkeys
$2,454,521Jan Johansson · Artery Therapeutics, Inc. · R44 · FY2025 · AG
Neurobiology and Target Validation of Novel Therapeutic Agents in Mood Disorders
$2,454,519Carlos Zarate · National Institute Of Mental Health · ZIA · FY2019 · MH
Alcohol Pharmacokinetics and Pharmacodynamics in Humans
$2,454,429Vijay Arjun Ramchandani · National Institute On Alcohol Abuse And Alcoholism · ZIA · FY2019 · AA
Pelvic floor Disorders Network-Data Coordinating Center
$2,454,210Catherine A Spino · University Of Michigan At Ann Arbor · U01 · FY2007 · HD
MarkVCID Validation in the General Community
$2,454,154Ronald C Petersen · Mayo Clinic Rochester · UF1 · FY2021 · NS
NEW APPROACHES TO SURGICAL ONCOLOGY
$2,454,143Donald L Morton · Saint John'S Cancer Institute · P01 · FY2008 · CA
SPORE in Soft Tissue Sarcoma
$2,453,831Samuel Singer · Sloan-Kettering Inst Can Research · P50 · FY2025 · CA
Alzheimer's Disease Research Center
$2,453,626University Of California San Diego · P50 · FY2004 · AG
Development of Novel Vaccine Strategies
$2,453,605Jeffrey Schlom · Basic Sciences · Z01 · FY2007 · CA
Transforming Human Pancreatic Cancer Into An Immunologic Disease
$2,453,222Elizabeth Marion Jaffee · Johns Hopkins University · P01 · FY2024 · CA
Long-Acting Parathyroid Hormone Analog for the Treatment of Hypoparathyroidism
$2,453,144Na Yang · National Center For Advancing Translational Sciences · ZIA · FY2017 · TR
Use of Rapamycin for the Treatment of Hypertrophic Cardiomyopathy in Patients with LEOPARD Syndrome
$2,453,144Elizabeth Ottinger · National Center For Advancing Translational Sciences · ZIA · FY2017 · TR
A controlled trial of patient centered telepsychiatry interventions
$2,452,907Peter M Yellowlees · University Of California At Davis · R01 · FY2013 · HS
Clot Lysis: Evaluating Accelerated Resolution of IVH Phase III (CLEAR III)
$2,452,564Daniel F Hanley · Johns Hopkins University · U01 · FY2013 · NS